Published in N Engl J Med on December 02, 1982
Lung cancer following therapy for Hodgkin's disease. Can Med Assoc J (1985) 1.38
Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide. Br J Cancer (1987) 1.15
Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs. Occup Environ Med (1994) 0.96
Multiple primary cancers in Connecticut, 1935-82. Yale J Biol Med (1987) 0.87
Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study. Br J Cancer (1987) 0.86
High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease. Br J Ophthalmol (1990) 0.80
Myeloid leukaemia following therapy for a first primary cancer. Br J Cancer (1991) 0.77
Update in cancer chemotherapy: genitourinary tract cancer, Part 5: Ovarian cancer. J Natl Med Assoc (1988) 0.75
Subsequent primary cancers in relation to treatment of ovarian cancer. Br J Cancer (1989) 0.75
Optimal chemotherapy for ovarian carcinoma: discussion paper. J R Soc Med (1984) 0.75
Evaluation of protective effect of amifostine on dacarbazine induced genotoxicity. Res Pharm Sci (2015) 0.75
Second look laparotomy in the management of epithelial cell carcinoma of the ovary. Br J Cancer (1984) 0.75
Autopsy Analysis may Contribute to Establish Actual Incidence of Second Primary Malignancies in Myeloma. Rare Tumors (2015) 0.75
Chronic myelocytic leukemia as a secondary malignant condition in a patient receiving prolonged chemotherapy for ovarian carcinoma. West J Med (1985) 0.75
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res (1995) 5.72
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med (1987) 4.12
Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. J Natl Cancer Inst (1997) 3.89
Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med (1988) 3.62
Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst (1993) 3.52
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol (1984) 3.21
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer (1993) 2.96
Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol (1994) 2.93
Risk of breast cancer following low-dose radiation exposure. Radiology (1979) 2.86
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst (2001) 2.59
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54
The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst (1998) 2.53
Residential radon exposure and lung cancer among nonsmoking women. J Natl Cancer Inst (1994) 2.45
Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst (1995) 2.35
Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med (1992) 2.34
Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J Natl Cancer Inst (1995) 2.30
Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer Suppl (1978) 2.28
Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol (1984) 2.25
Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol (1996) 2.21
Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. Gynecol Oncol (2001) 2.18
Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet (2005) 2.13
Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst (1987) 2.12
Cellular telephones and risk for brain tumors: a population-based, incident case-control study. Neurology (2005) 2.11
Leukaemia incidence after iodine-131 exposure. Lancet (1992) 2.05
Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer (1980) 2.04
Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01
Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst (1985) 2.00
A population-based case-control study of thyroid cancer. J Natl Cancer Inst (1987) 1.98
Indoor radon and lung cancer in China. J Natl Cancer Inst (1990) 1.95
Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol (1991) 1.83
Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA (1998) 1.82
Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res (1991) 1.77
Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women. J Natl Cancer Inst (1980) 1.76
Femoral vessel depth and the implications for groin node radiation. Int J Radiat Oncol Biol Phys (1993) 1.75
Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA (1978) 1.74
The dynamics of a heroin addiction epidemic. Science (1973) 1.74
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci U S A (1983) 1.72
Breast cancer in women after repeated fluoroscopic examinations of the chest. J Natl Cancer Inst (1977) 1.69
Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol (1994) 1.68
A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol (1989) 1.67
Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. J Clin Oncol (1998) 1.67
Cancer among epileptic patients exposed to anticonvulsant drugs. J Natl Cancer Inst (1989) 1.66
Cancer in populations living near nuclear facilities. A survey of mortality nationwide and incidence in two states. JAMA (1991) 1.65
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study. J Clin Oncol (1994) 1.62
Cancer in the parents of children with cancer. N Engl J Med (1995) 1.61
Estimating Rn-induced lung cancer in the United States. Health Phys (1989) 1.61
Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol (1992) 1.60
Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol (1985) 1.56
Second-look laparotomy in ovarian germ cell tumors: the gynecologic oncology group experience. Gynecol Oncol (1994) 1.55
Amyl nitrite may alter T lymphocytes in homosexual men. Lancet (1982) 1.54
Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst (2000) 1.54
A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer (1983) 1.54
Adjusting lung cancer risks for temporal and spatial variations in radon concentration in dwellings in Gansu Province, China. Radiat Res (2005) 1.54
Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81. J Natl Cancer Inst (1984) 1.54
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res (2003) 1.54
Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol (1999) 1.53
Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism. J Natl Cancer Inst (1978) 1.53
Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer (1995) 1.52
High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med (1985) 1.51
Thyroid nodularity and chromosome aberrations among women in areas of high background radiation in China. J Natl Cancer Inst (1990) 1.49
Second cancers following non-Hodgkin's lymphoma. Cancer (1991) 1.49
Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone. Int J Radiat Oncol Biol Phys (1992) 1.45
Glycophorin A biodosimetry in Chernobyl cleanup workers from the Baltic countries. BMJ (1996) 1.45
Radiation risk estimates for leukemia and thyroid cancer among Russian emergency workers at Chernobyl. Radiat Environ Biophys (1997) 1.44
Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study) Am J Obstet Gynecol (1989) 1.44
A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol (1985) 1.43
Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol (1990) 1.42
Lung cancer after Hodgkin's disease. J Natl Cancer Inst (1995) 1.42
Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: lessons learned from a Gynecologic Oncology Group phase II trial of ip cisplatin and recombinant alpha-interferon. Gynecol Oncol (1992) 1.42
Seminoma of the testis: results of treatment and patterns of failure after radiation therapy. Int J Radiat Oncol Biol Phys (1982) 1.41
Adult leukemia following diagnostic x-rays? (Review of report by BROSS, BALL, and FALEN on a tri-state leukemia survey). Am J Public Health (1979) 1.39
Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy. Am J Hum Genet (1986) 1.39
Breast cancer in women with scoliosis exposed to multiple diagnostic x rays. J Natl Cancer Inst (1989) 1.39
Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res (1989) 1.37
Prenatal x-ray exposure and childhood cancer in twins. N Engl J Med (1985) 1.35
Malignant melanoma in renal-transplant recipients. Lancet (1981) 1.33
Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res (1999) 1.33
Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol (1985) 1.32
Thyroid neoplasia following low-dose radiation in childhood. Radiat Res (1989) 1.32
Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet (1982) 1.31
Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients. Cancer (1991) 1.29
Residential radon exposure and lung cancer in Swedish women. Health Phys (1992) 1.27
Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol (1996) 1.27
Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol (1997) 1.26
Familial and sporadic Hodgkin's disease associated with occupational wood exposure. Lancet (1978) 1.26
Radiation-induced skin carcinomas of the head and neck. Radiat Res (1991) 1.26
Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol (1996) 1.25
A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study. Cancer (1986) 1.25
Second malignant neoplasms among long-term survivors of ovarian cancer. Cancer Res (1996) 1.25
Radiogenic male breast cancer with in vitro sensitivity to ionizing radiation and bleomycin. Cancer Invest (1983) 1.24
Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol (1980) 1.24
Melphalan may be a more potent leukemogen than cyclophosphamide. Ann Intern Med (1986) 1.23